Last reviewed · How we verify
Risedronate Sodium 150 MG — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Risedronate Sodium 150 MG (Risedronate Sodium 150 MG) — Wake Forest University Health Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Risedronate Sodium 150 MG TARGET | Risedronate Sodium 150 MG | Wake Forest University Health Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Risedronate Sodium 150 MG CI watch — RSS
- Risedronate Sodium 150 MG CI watch — Atom
- Risedronate Sodium 150 MG CI watch — JSON
- Risedronate Sodium 150 MG alone — RSS
Cite this brief
Drug Landscape (2026). Risedronate Sodium 150 MG — Competitive Intelligence Brief. https://druglandscape.com/ci/risedronate-sodium-150-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab